SUBSEQUENT EVENTS	3 Months Ended
Mar. 31, 2026
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 16 - SUBSEQUENT EVENTS Besser Initial Restricted Stock Units On April 4, 2026, in connection with, and pursuant to the terms of that certain Amended and Restated Employment Agreement with Doron Besser, dated as of December 17, 2025, as amended on February 2, 2026, the Board approved, as recommended by the Compensation Committee (i) an award of 1,044,741 fully vested restricted stock units (the “Besser Initial RSUs”) with a date of grant as of April 4, 2026 (the “Initial Grant Date”), subject to the terms and conditions of the 2024 Plan; and (ii) on each quarterly anniversary of the Initial Grant Date, subject to the authorized share limit under the 2024 Plan, an additional gross-up award, if necessary, in order for Dr. Besser to maintain 9.0% of the Company’s issued and outstanding Common Stock, determined on a fully diluted basis as of the grant date of such applicable quarterly gross-up award. Following Board approval, the Besser Initial RSUs were granted to Dr. Besser on the Initial Grant Date. Series H Preferred Stock — Additional Investment Right and Conversions On April 23, 2026, the Alpha exercised $1,700 of the Additional Investment Right pursuant to the July Purchase Agreement, resulting in the issuance of 1,700 new shares of Series H Preferred Stock at a stated value of $1,000 per share (not in thousand). During the months of April and May 2026, the Alpha also converted an aggregate of 1,252 shares of Series H Preferred Stock into 1,201,305 shares of Common Stock and aggregate of $151 of accrued dividends into 144,886 shares of Common Stock.

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2026

NOTE 16 - SUBSEQUENT EVENTS

Besser Initial Restricted Stock Units

On April 4, 2026, in connection with, and pursuant to the terms of that certain Amended and Restated Employment Agreement with Doron Besser, dated as of December 17, 2025, as amended on February 2, 2026, the Board approved, as recommended by the Compensation Committee (i) an award of 1,044,741 fully vested restricted stock units (the “Besser Initial RSUs”) with a date of grant as of April 4, 2026 (the “Initial Grant Date”), subject to the terms and conditions of the 2024 Plan; and (ii) on each quarterly anniversary of the Initial Grant Date, subject to the authorized share limit under the 2024 Plan, an additional gross-up award, if necessary, in order for Dr. Besser to maintain 9.0% of the Company’s issued and outstanding Common Stock, determined on a fully diluted basis as of the grant date of such applicable quarterly gross-up award. Following Board approval, the Besser Initial RSUs were granted to Dr. Besser on the Initial Grant Date.

Series H Preferred Stock — Additional Investment Right and Conversions

On April 23, 2026, the Alpha exercised $1,700 of the Additional Investment Right pursuant to the July Purchase Agreement, resulting in the issuance of 1,700 new shares of Series H Preferred Stock at a stated value of $1,000 per share (not in thousand).

During the months of April and May 2026, the Alpha also converted an aggregate of 1,252 shares of Series H Preferred Stock into 1,201,305 shares of Common Stock and aggregate of $151 of accrued dividends into 144,886 shares of Common Stock.